The epidemiological curve of the Covid-19 in Sardinia continues to improve. In the week between 25 November and 1 December, the Gimbe Foundation records, in fact, an improvement in the incidence per 100,000 inhabitants (207.6) with a 6.6% decrease in new cases compared to the previous week.

The lowest incidence is recorded in Southern Sardinia (171 cases per 100 thousand inhabitants and -12.3% compared to the previous week), while the highest in the metropolitan city of Cagliari (249 and -9.5%). The only negative figure comes from the province of Oristan with an increase of +28.2%, even if the incidence remains among the lowest on the island (176 per 100,000 inhab.), even lower than in the Sassari area ( 207 -5.3% compared to the previous week) and of the Nuoro area (196 and -9.8% compared to the previous week).

The number of beds in the medical area (5.3%) and in intensive care (2.9%) occupied by Covid patients remain below the national average.

As far as the vaccination campaign is concerned, the slowdown in administrations is confirmed: the percentage of the over 5 year old population that has not received any vaccine dose is 11% (Italian average 10.6%) to which must be added the over 5 population years temporarily protected, as recovered from Covid-19 for less than 180 days, equal to 1%.

The population over 5 years who has not received the third dose of vaccine is 14.4% (Italian average 11.8%) to which must be added the population over 5 years healed for less than 120 days, who cannot receive the third immediate dose, equal to 3.3%. The vaccination coverage rate with a fourth dose is 19% (Italian average 26.9%).

Among the youngest (5-11 years) only 41.7% completed the vaccination cycle (Italian average 35.3%) to add a further 4.5% (Italian average 3.3%) only with the first dose .

However - notes the president of the Foundation, Nino Cartabellotta - "the number of new weekly cases is no longer a reliable indicator of viral circulation, underestimated by at least 50%". This "both for the widespread use of 'do-it-yourself' tampons, he specifies, and for the lack of testing of asymptomatic or paucisymptomatic people".

(Unioneonline/vl)

© Riproduzione riservata